| Literature DB >> 29196901 |
Mahsa Yarhosseini1, Shahrzad Javanshir2, Zahra Dolatkhah1, Mohammad G Dekamin1.
Abstract
A simple solvent-free protocol for the preparation of flunixin, a potent non-narcotic, non-steroidal anti-inflammatory drugs is reported using boric acid as catalyst. Its salt, flunixin meglumine are then prepared under reflux in EtOH. This sustainable method are then extended for the synthesis of a series of 2-(arylamino) nicotinic acid derivatives. The present protocol combines non-hazardous neat conditions with associated benefits like excellent yield, straightforward workup, and use of readily available and safe catalyst in the absence of any solvent, which are important factors in the pharmaceutical industry. The pathway for catalytic activation of 2-chloronicotic acid with boric acid was also investigated using Gaussian 03 program package.Entities:
Keywords: Anilino-nicotinic acid; Boric acid; Homogeneous catalysis; N-Methyl-D-glucamine; Non-steroidal anti-inflammatory drugs (NSAID); Solvent-free
Year: 2017 PMID: 29196901 PMCID: PMC5711764 DOI: 10.1186/s13065-017-0355-4
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Fig. 1Chemical structure of flunixin
Scheme 1Synthesis of flunixin meglumine
Optimization of the reaction conditions for the synthesis of (3a)
| Entry | Ratio of 1/2 | Catalyst | Catalyst loading (mole %) | Solvent | Temp (°C) | Time (h) | Yieldc (%) |
|---|---|---|---|---|---|---|---|
| 1 | 2:1 | – | – | H2O | Reflux | 24 | – |
| 2 | 2:1 | – | – | – | 100 | 10 | 35 |
| 3 | 2:1 | K2CO3 | 15 | – | 100 | 24 | Trace |
| 4 | 2:1 | NEt3 | 15 | – | 100 | 24 | – |
| 5 | 2:1 | K2CO3 | 15 | H2O | Reflux | 24 | Trace |
| 6 | 2:1 | NEt3 | 15 | H2O | Reflux | 24 | – |
| 7 | 2:1 | Fe3O4 | 15 | H2O | Reflux | 24 | – |
| 8 | 2:1 | DABCOa | 15 | H2O | Reflux | 24 | Trace |
| 9 | 2:1 | PTSA | 15 | H2O | Reflux | 24 | 65 |
| 10 | 2:1 | H3BO3 | 15 | H2O | Reflux | 24 | 60 |
| 11 | 2:1 | H3BO3 | 15 | EtOH | Reflux | 24 | 40 |
| 12 | 2:1 | H3BO3 | 15 |
| Reflux | 24 | 62 |
| 13 | 2:1 | H3BO3 | 15 | PEG-400b | Reflux | 24 | 30 |
| 14 | 2:1 | H3BO3 | 15 | DMF | Reflux | 24 | 45 |
| 15 | 2:1 | H3BO3 | 15 | Xylene | Reflux | 24 | Trace |
| 14 | 2:1 | H3BO3 | 15 | Toluene | Reflux | 24 | 50 |
| 17 | 2:1 | H3BO3 | 15 | – | 100 | 10 | 68 |
| 18 | 2:1 | H3BO3 | 30 | – | 100 | 10 | 82 |
| 19 | 2:1 | H3BO3 | 48 | – | 100 | 10 | 84 |
| 20 | 2:1 | H3BO3 | 30 | – | 80 | 12 | 45 |
|
| 2:1 |
|
| – |
|
|
|
| 22 | 2:1 | H3BO3 | 30 | – | 150 | 10 | 90 |
| 23 | 2:1 | PTSA | 30 | – | 120 | 9 | 90 |
| 24 | 1:1 | H3BO3 | 30 | – | 120 | 20 | 60 |
Reaction conditions: 2-methyl-3-trifluoromethylanilin (2 mmol), 2-chloronicotinic acid (1 mmol)
The optimum reaction conditions are in italics
a1,4-diazabicyclo[2.2.2]octane
bPolyethylene glycol
cThe yields refer to the isolated product
Scheme 2Scalability of the reaction to the multi-gram scale
Results of the synthesis of 2-arylaminonicotinic acids derivatives 3(b–l) under solvent-free conditions
|
| |||||
|---|---|---|---|---|---|
| Entry | Anilines | Products | Time (min) | Yielda (%) | Mp (°C) |
| 1 | 2-Chloroaniline |
| 20 | 62 | 213–215 |
| 2 | 2,6-Dichloroaniline |
| 60 | 25 | 264–267 |
| 3 | 3,4-Dichloroaniline |
| 25 | 72 | 258–260 |
| 4 | 2,3-Dichloroaniline |
| 25 | 58 | 256 |
| 5 | 2,4-Dimethylaniline |
| 10 | 92 | 225–227 |
| 6 | 3-Nitroaniline |
| 30 | 90 | 218–219 |
| 7 | 4-Nitroaniline |
| 60 | 28 | 274–275 |
| 8 | 1-Naphthylamine |
| 30 | 85 | 191–194 |
| 9 | 2-Aminophenol |
| 25 | 88 | 230–232 |
| 10 | Methylamine |
| – | – | – |
| 11 | Buthylamine |
| – | – | – |
| 12 | Phenylethylamine |
| – | – | [228–230] [ |
Reaction conditions: amines (2 mmol), nicotinic acid (1 mmol), and 20 mg H3BO3 at 120 °C under solvent-free condition
aThe yields refer to the isolated product
Scheme 3Nucleophilic substitution of a pyridine ring
Scope in pyridine analogues for nucleophilic aromatic substitution
| Entry | Substrate | Nucleophile | Time (h) | Yield (%) |
|---|---|---|---|---|
| 1 |
|
| 12 | – |
| 2 |
|
| 12 | – |
| 3 |
|
| 12 | – |
Reaction conditions: aniline (2 mmol), pyridine analogues (1 mmol), and 20 mg (0.3 mmol) H3BO3 at 120 °C under solvent-free condition
Fig. 2Optimization conditions for the synthesis of (6). Reaction conditions: flunixin (1 mmol), meglumine (1 mmol). *The yields refer to the isolated product
Fig. 3Two possible pathway for catalytic activation of 2-chloronicotic acid with Boric acid. a HBD, b Boron-Nitrogen Lewis acid–base interaction
Fig. 4The optimized structures of nicotinic acid-boric acid, IMs, and product for pathway (a, b) by B3lyp/6-311G (d, p) singlet in the gas phase
The optimized bond lengths (in nm) and stability energies E (a.u.) computed at B3LYP/6-311G (d, p) level of theory for IMA, IMB, TS, PA, and PB (see Fig. 4 for atoms numbering)
| Bond length (nm) | IMA | IMB | TS | PA | PB |
|---|---|---|---|---|---|
| (N6–H19) | 1.92 | 1.95 | 1.92 | 1.92 | |
| (C1–Cl10) | 1.75 | 1.75 | 2.04 | ||
| (C1–N22) | 1.91 | 1.37 | 1.37 | ||
| E (stability energies in a.u.) | − 1149.199 a.u. | − 1149.193 a.u. | − 1352.544 a.u. | − 1352.544 a.u. |
Scheme 4Plausible mechanisms for the synthesis of flunixin